Credit Suisse Initiates Prosensa With Neutral

Analysts at Credit Suisse initiated coverage on shares of Prosensa RNA with a Neutral rating. The target price for Prosensa is set to $9. Prosensa shares have gained 44.94% over the past 52 weeks, while the S&P 500 index has surged 17.13% in the same period. Prosensa's shares rose 1.93% to close at $8.45 yesterday.